15 April 2020
Visiongain has launched a new pharma report: Biopharmaceuticals Excipients Market 2020-2030: Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others.
Pharmaceutical excipients (also known as bulking agent, filler, diluent) are substances formulated with the active ingredient of a drug. They are included in a pharmaceutical dosage form for a special purpose, such as to aid the manufacturing process and to support enhance stability of drugs. Excipients are also useful for product identification and for the enhancement of overall safety and functionality of the product during usage and storage.
The lead analyst of the report commented "Major factors fuelling growth in this market include overall growth in the biopharmaceutical industry and the increasing burden of chronic diseases which surges the demand for innovative and advanced drugs for treatment. The major challenge faced in this industry is the high cost of drug manufacturing, which is compounded by a strict regulatory environment. Government initiatives and increasing research in the development of innovative biopharmaceutical drugs are promising opportunities for market growth."
Leading companies featured in the report include ABITEC Corp, Signet Chemical Corporation, Roquette Freres SA, Sigachi Industries, MEGGLE AG & Other Companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
03 July 2020
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
03 July 2020
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
01 July 2020
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.